Ascend Wellness Holdings (AAWH) Total Liabilities (2020 - 2026)
Ascend Wellness Holdings (AAWH) posted quarterly Total Liabilities of $947.9 million for Q1 2026, up 9.7% year-over-year from $864.0 million in Q1 2025, and down 0.7% quarter-over-quarter from $954.5 million in Q4 2025.
Ascend Wellness Holdings (AAWH) Total Liabilities (2020 - 2026) Analysis & Trends
Ascend Wellness Holdings' Total Liabilities history runs 7 years deep, the most recent figure standing at $947.9 million for Q1 2026.
- In Q1 2026, Total Liabilities rose 9.7% year-over-year to $947.9 million; the TTM figure through Mar 2026 stood at $947.9 million (up 9.7% YoY), while the FY2025 annual figure was $954.5 million, up 15.2% from the prior year.
- Total Liabilities for Q1 2026 stood at $947.9 million, down from $954.5 million in the prior quarter.
- The five-year high for Total Liabilities was $954.5 million in Q4 2025, with the low at $556.2 million in Q1 2022.
- The 5-year median for Total Liabilities is $786.0 million (2024), against an average of $784.3 million.
- The sharpest annual moves came in 2022 and 2024: Total Liabilities soared 64.9% in 2022, then rose 6.69% in 2024.
- Ascend Wellness Holdings' Total Liabilities stood at $708.7 million in 2022, then climbed by 9.58% to $776.7 million in 2023, then grew by 6.69% to $828.6 million in 2024, then climbed by 15.2% to $954.5 million in 2025, then declined by 0.7% to $947.9 million in 2026.
- Business Quant data shows AAWH's Total Liabilities at $947.9 million in Q1 2026, $954.5 million in Q4 2025, and $897.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | -21.66 Bn |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 32.10 Bn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | 11.93 Bn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | 50.85 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | 819.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 20.78 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 1.67 Bn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 6.97 Bn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 2.12 Bn |
| 10 | Ascend Wellness Holdings | 83.23 Mn | 16.23 Mn | 45.49 Mn | 973.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 973.41 Mn |
| Mar 31, 2026 | 947.86 Mn |
| Dec 31, 2025 | 954.55 Mn |
| Sep 30, 2025 | 897.78 Mn |
| Jun 30, 2025 | 875.71 Mn |
| Mar 31, 2025 | 864.03 Mn |
| Dec 31, 2024 | 828.63 Mn |
| Sep 30, 2024 | 806.96 Mn |
| Jun 30, 2024 | 811.82 Mn |
| Mar 31, 2024 | 786.03 Mn |
| Dec 31, 2023 | 776.68 Mn |
| Sep 30, 2023 | 748.52 Mn |
| Jun 30, 2023 | 733.61 Mn |
| Mar 31, 2023 | 721.13 Mn |
| Dec 31, 2022 | 708.75 Mn |
| Sep 30, 2022 | 673.15 Mn |
| Jun 30, 2022 | 642.17 Mn |
| Mar 31, 2022 | 556.18 Mn |
| Dec 31, 2021 | 546.96 Mn |
| Sep 30, 2021 | 532.85 Mn |